Company Filing History:
1 out of 2,009 
1 out of 504 
Years Active: 2025
Title: Clare Burn: Innovator in Monoclonal Antibodies
Introduction
Clare Burn is a notable inventor based in the Bronx, NY (US). She has made significant contributions to the field of medicine, particularly in the development of monoclonal antibodies for the prevention and treatment of herpes simplex viral infections. Her work has the potential to impact many lives by providing effective therapeutic options.
Latest Patents
Clare Burn holds a patent for "Monoclonal antibodies for prevention and treatment of herpes simplex viral infections." This patent includes antibodies and antigen-binding fragments that specifically bind to herpes simplex virus-2 (HSV-2). The patent also outlines methods of use employing these antibodies and/or antigen-binding fragments, as well as pharmaceutical compositions that incorporate them. She has 1 patent to her name.
Career Highlights
Throughout her career, Clare Burn has worked with prestigious institutions such as Duke University and Albert Einstein College of Medicine. Her research has focused on innovative solutions to combat viral infections, showcasing her dedication to advancing medical science.
Collaborations
Clare has collaborated with esteemed colleagues, including Betsy C. Herold and Garnett Kelsoe. These partnerships have further enriched her research and contributed to the development of her patented technologies.
Conclusion
Clare Burn's work in the field of monoclonal antibodies represents a significant advancement in the treatment of herpes simplex viral infections. Her innovative approach and dedication to research continue to inspire future developments in medical science.